MedTrace Logo

MBCT for People With Parkinson's Disease and Caregivers

NCT04469049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2021-10-05

No results posted yet for this study

Summary

This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease (PD) and caregivers of people with PD.

Conditions

Interventions

BEHAVIORAL

Mindfulness-based cognitive therapy (MBCT)

MBCT is an evidence-based psychotherapy which combines mindfulness skills with cognitive therapy strategies.

Sponsors & Collaborators

Principal Investigators

  • Andreea L. Seritan, MD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-11
Primary Completion
2021-06-11
Completion
2021-06-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04469049 on ClinicalTrials.gov